1.
Parimi S, Bondy S, Tsang E, McKenzie MR, Bachand F, Aparicio M, et al. Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer. CUAJ [Internet]. 2018 Dec. 4 [cited 2026 May 5];13(10):E311-6. Available from: https://cuaj.ca/index.php/journal/article/view/5685